Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	The Angels Initiative Stroke prevention

Breast Cancer

Free Subscription Articles published in PLoS Comput Biol Retrieve available abstracts of 23 articles: HTML format

Single Articles

April 2022
1. LEE D, Wang D, Yang XR, Shi J, et al
   SUITOR: Selecting the number of mutational signatures through cross-validation.
   PLoS Comput Biol. 2022;18:e1009309.
   PubMed     Abstract available
   
   
   March 2022
2. HOWARD GR, Jost TA, Yankeelov TE, Brock A, et al
   Quantification of long-term doxorubicin response dynamics in breast cancer cell lines to direct treatment schedules.
   PLoS Comput Biol. 2022;18:e1009104.
   PubMed     Abstract available
   
   
   
3. JEUKEN GS, Tobin NP, Kall L
   Survival analysis of pathway activity as a prognostic determinant in breast cancer.
   PLoS Comput Biol. 2022;18:e1010020.
   PubMed     Abstract available
   
   
   
4. MOHAMMAD MIRZAEI N, Changizi N, Asadpoure A, Su S, et al
   Investigating key cell types and molecules dynamics in PyMT mice model of breast cancer through a mathematical model.
   PLoS Comput Biol. 2022;18:e1009953.
   PubMed     Abstract available
   
   
   
5. YAO K, Schaafsma E, Zhang B, Cheng C, et al
   Tumor cell intrinsic and extrinsic features predict prognosis in estrogen receptor positive breast cancer.
   PLoS Comput Biol. 2022;18:e1009495.
   PubMed     Abstract available
   
   
   February 2022
6. DI FILIPPO M, Pescini D, Galuzzi BG, Bonanomi M, et al
   INTEGRATE: Model-based multi-omics data integration to characterize multi-level metabolic regulation.
   PLoS Comput Biol. 2022;18:e1009337.
   PubMed     Abstract available
   
   
   November 2021
7. LIMA EABF, Faghihi D, Philley R, Yang J, et al
   Bayesian calibration of a stochastic, multiscale agent-based model for predicting in vitro tumor growth.
   PLoS Comput Biol. 2021;17:e1008845.
   PubMed     Abstract available
   
   
   
8. MADSSEN TS, Giskeodegard GF, Smilde AK, Westerhuis JA, et al
   Repeated measures ASCA+ for analysis of longitudinal intervention studies with multivariate outcome data.
   PLoS Comput Biol. 2021;17:e1009585.
   PubMed     Abstract available
   
   
   September 2021
9. LEE HG, Lee KJ
   Neighbor-enhanced diffusivity in dense, cohesive cell populations.
   PLoS Comput Biol. 2021;17:e1009447.
   PubMed     Abstract available
   
   
   
10. TRINCADO JL, Reixachs-Sole M, Perez-Granado J, Fugmann T, et al
    ISOTOPE: ISOform-guided prediction of epiTOPEs in cancer.
    PLoS Comput Biol. 2021;17:e1009411.
    PubMed     Abstract available
    
    
    July 2021
11. ROZOVA VS, Anwer AG, Guller AE, Es HA, et al
    Machine learning reveals mesenchymal breast carcinoma cell adaptation in response to matrix stiffness.
    PLoS Comput Biol. 2021;17:e1009193.
    PubMed     Abstract available
    
    
    
12. ZHU K, Cai L, Cui C, de Los Toyos JR, et al
    Single-cell analysis reveals the pan-cancer invasiveness-associated transition of adipose-derived stromal cells into COL11A1-expressing cancer-associated fibroblasts.
    PLoS Comput Biol. 2021;17:e1009228.
    PubMed     Abstract available
    
    
    June 2021
13. ERDEM C, Lee AV, Taylor DL, Lezon TR, et al
    Inhibition of RPS6K reveals context-dependent Akt activity in luminal breast cancer cells.
    PLoS Comput Biol. 2021;17:e1009125.
    PubMed     Abstract available
    
    
    
14. TRENTHAM-DIETZ A, Alagoz O, Chapman C, Huang X, et al
    Reflecting on 20 years of breast cancer modeling in CISNET: Recommendations for future cancer systems modeling efforts.
    PLoS Comput Biol. 2021;17:e1009020.
    PubMed     Abstract available
    
    
    
15. HELLSTERN M, Ma J, Yue K, Shojaie A, et al
    netgsa: Fast computation and interactive visualization for topology-based pathway enrichment analysis.
    PLoS Comput Biol. 2021;17:e1008979.
    PubMed     Abstract available
    
    
    
16. LAL A, Liu K, Tibshirani R, Sidow A, et al
    De novo mutational signature discovery in tumor genomes using SparseSignatures.
    PLoS Comput Biol. 2021;17:e1009119.
    PubMed     Abstract available
    
    
    
17. DEUTSCH A, Nava-Sedeno JM, Syga S, Hatzikirou H, et al
    BIO-LGCA: A cellular automaton modelling class for analysing collective cell migration.
    PLoS Comput Biol. 2021;17:e1009066.
    PubMed     Abstract available
    
    
    March 2021
18. CLIMENTE-GONZALEZ H, Lonjou C, Lesueur F, Stoppa-Lyonnet D, et al
    Boosting GWAS using biological networks: A study on susceptibility to familial breast cancer.
    PLoS Comput Biol. 2021;17:e1008819.
    PubMed     Abstract available
    
    
    February 2021
19. BEN-ELAZAR S, Aure MR, Jonsdottir K, Leivonen SK, et al
    miRNA normalization enables joint analysis of several datasets to increase sensitivity and to reveal novel miRNAs differentially expressed in breast cancer.
    PLoS Comput Biol. 2021;17:e1008608.
    PubMed     Abstract available
    
    
    
20. SUSAK H, Serra-Saurina L, Demidov G, Rabionet R, et al
    Efficient and flexible Integration of variant characteristics in rare variant association studies using integrated nested Laplace approximation.
    PLoS Comput Biol. 2021;17:e1007784.
    PubMed     Abstract available
    
    
    January 2021
21. GORDIN M, Philip H, Zilberberg A, Gidoni M, et al
    Breast cancer is marked by specific, Public T-cell receptor CDR3 regions shared by mice and humans.
    PLoS Comput Biol. 2021;17:e1008486.
    PubMed     Abstract available
    
    
    November 2020
22. SETHI R, Becker J, Graaf J, Lower M, et al
    Integrative analysis of structural variations using short-reads and linked-reads yields highly specific and sensitive predictions.
    PLoS Comput Biol. 2020;16:e1008397.
    PubMed     Abstract available
    
    
    September 2020
23. VAN DER KLOET FM, Buurmans J, Jonker MJ, Smilde AK, et al
    Increased comparability between RNA-Seq and microarray data by utilization of gene sets.
    PLoS Comput Biol. 2020;16:e1008295.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Breast Cancer is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: